EUR 1.24
(-2.97%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 63.96 Million EUR | -18.32% |
2022 | 78.3 Million EUR | -10.52% |
2021 | 87.51 Million EUR | 345.3% |
2020 | 19.65 Million EUR | 39.05% |
2019 | 14.13 Million EUR | 37.74% |
2018 | 10.26 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 57.37 Million EUR | -5.27% |
2024 Q1 | 61.92 Million EUR | -3.18% |
2024 Q2 | 60.56 Million EUR | -2.2% |
2023 Q3 | 63.96 Million EUR | -12.6% |
2023 FY | 63.96 Million EUR | -18.32% |
2023 Q4 | 63.96 Million EUR | 0.0% |
2023 Q2 | 73.18 Million EUR | 0.0% |
2023 Q1 | - EUR | -100.0% |
2022 Q2 | 83.29 Million EUR | 0.0% |
2022 FY | 78.3 Million EUR | -10.52% |
2022 Q4 | 78.3 Million EUR | 0.0% |
2022 Q3 | 78.3 Million EUR | -5.99% |
2022 Q1 | - EUR | -100.0% |
2021 Q4 | 87.51 Million EUR | 0.0% |
2021 Q1 | - EUR | -100.0% |
2021 FY | 87.51 Million EUR | 345.3% |
2021 Q2 | 25.18 Million EUR | 0.0% |
2021 Q3 | 87.51 Million EUR | 247.45% |
2020 FY | 19.65 Million EUR | 39.05% |
2020 Q4 | 19.65 Million EUR | 0.0% |
2019 FY | 14.13 Million EUR | 37.74% |
2018 FY | 10.26 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | 10.61 Million EUR | -502.676% |
Nexstim Plc | 9.88 Million EUR | -547.186% |
Revenio Group Oyj | 137.4 Million EUR | 53.448% |